Pharmaceutical Intermediates Global Market Opportunities And Strategies To 2033

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $4,000	326 Pages	The Business Research Company	March, 2024	BRC18636747

Best Price Guarantee
Price	from $4,000
Length	326 Pages
Publisher	The Business Research Company
Published Date	March, 2024
SKU	BRC18636747

Pharmaceutical Intermediates Global Market Opportunities And Strategies To 2033

Including: 1) By Product: Chemical Intermediate; Bulk Drug Intermediate2) By Category: Branded Drug Intermediate; Generic Drug Intermediate3) By Application: Oncology Drugs; Anti-Infective Drugs; Central Nervous System Drugs; Respiratory Diseases Drugs; Cardiovascular Drugs; Musculoskeletal Disorders Drugs; Metabolic Disorders Drugs4) By End-User: Biotech And Pharma Companies; Research InstitutionsCovering: BASF SE; Evonik Industries AG; Pfizer Inc.; Arkema Inc.; Koninklijke DSM N.V.

Pharmaceutical Intermediates Global Market Opportunities And Strategies To 2033 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global pharmaceutical intermediates market as it emerges from the COVID-19 shut down.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market research findings.
Benchmark performance against key competitors.
Utilize the relationships between key data sets for superior strategizing.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis

Description:

Where is the largest and fastest-growing market for pharmaceutical intermediates? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The pharmaceutical intermediates market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market’s history and forecasts market growth by geography. It places the market within the context of the wider pharmaceutical intermediates market; and compares it with other markets.

The report covers the following chapters

Introduction And Market Characteristics

Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by product, by category, by application and by end-user.

Key Trends

Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.

Macro-Economic Scenario

The report provides an analysis of the impact of the COVID-19 pandemic, impact of the Russia-Ukraine war and impact of rising inflation on global and regional markets, providing strategic insights for businesses in the pharmaceutical intermediates market.

Global Market Size And Growth

Global historic (2018-2023) and forecast (2023-2028, 2033F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.

Regional And Country Analysis

Historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison by region and country.

Market Segmentation

Contains the market values (2018-2023) (2023-2028, 2033F) and analysis for each segment by product, segmentation by category, by application and by end-user in the market. Historic (2018-2023) and forecast (2023-2028) and (2028-2033) market values and growth and market share comparison by region market.

Regional Market Size And Growth

Regional market size (2023), historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.

Competitive Landscape

Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.

Other Major And Innovative Companies

Details on the company profiles of other major and innovative companies

Competitive Benchmarking

Briefs on the financials comparison between major players in the market

Competitive Dashboard

Briefs on competitive dashboard of major players.

Key Mergers And Acquisitions

Information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.

Market Opportunities And Strategies

Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.

Conclusions And Recommendations

This section includes recommendations for the pharmaceutical intermediates providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.

Appendix

This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Scope

Markets Covered:

1) By Product: Chemical Intermediate; Bulk Drug Intermediate; Other Products

2) By Category: Branded Drug Intermediate; Generic Drug Intermediate

3) By Application: Oncology Drugs; Anti-Infective Drugs; Central Nervous System Drugs; Respiratory Diseases Drugs; Cardiovascular Drugs; Musculoskeletal Disorders Drugs; Metabolic Disorders Drugs; Other Applications

4) By End-User: Biotech And Pharma Companies; Research Institutions; Other End-Users

Companies Mentioned: BASF SE; Evonik Industries AG; Pfizer Inc; Arkema Inc; Koninklijke DSM N.V.

Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; UK; Italy; Spain; Russia

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time-series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; pharmaceutical intermediates indicators comparison.

Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

1 Executive Summary: 1.1 Pharmaceutical Intermediates – Market Attractiveness And Macro economic Landscape
2 Table Of Contents
3 List Of Tables
4 List Of Figures
5 Report Structure
6 Market Characteristics: 6.1 General Market Definition; 6.2 Summary; 6.3 Pharmaceutical Intermediates Market Definition And Segmentations; 6.4 Market Segmentation By Product; 6.4.1 Chemical Intermediate; 6.4.2 Bulk Drug Intermediate; 6.4.3 Other Products; 6.5 Market Segmentation By Category; 6.5.1 Branded Drug Intermediate; 6.5.2 Generic Drug Intermediate; 6.6 Market Segmentation By Application; 6.6.1 Oncology Drugs; 6.6.2 Anti-Infective Drugs; 6.6.3 Central Nervous System Drugs; 6.6.4 Respiratory Diseases Drugs; 6.6.5 Cardiovascular Drugs; 6.6.6 Musculoskeletal Disorders Drugs; 6.6.7 Metabolic Disorders Drugs; 6.6.8 Other Applications; 6.7 Market Segmentation By End-User; 6.7.1 Biotech And Pharma Companies; 6.7.2 Research Institutions; 6.7.3 Other End-Users
7 Major Market Trends: 7.1 Innovative AI Solutions For Seamless Integration Of Drug Discovery And Synthesis; 7.2 Strategic Partnerships And Acquisitions Among Market Players To Drive Innovation In The Market; 7.3 Innovative Product Launches To Support The Evolution Of Safe And Effective Medicines; 7.4 Focus On Production Facility Expansions; 7.5 Quick Response (QR) Code Labelling To Track All Drug-Related Information; 7.6 Focus On Green Chemistry To Reduce The Environmental Impact Of Synthetic Chemistry
8 Pharmaceutical Intermediates Market - Macro Economic Scenario: 8.1 COVID-19 Impact On The Pharmaceutical Intermediates Market; 8.2 Impact Of The War In Ukraine On The Pharmaceutical Intermediates Market; 8.3 Impact Of High Inflation On The Pharmaceutical Intermediates Market
9 Global Market Size and Growth: 9.1 Market Size; 9.2 Historic Market Growth, 2018 – 2023, Value ($ Million); 9.2.1 Market Drivers 2018 – 2023; 9.2.2 Market Restraints 2018 – 2023; 9.3 Forecast Market Growth, 2023 – 2028, 2033F Value ($ Million); 9.3.1 Market Drivers 2023 – 2028; 9.3.2 Market Restraints 2023 – 2028
10 Global Pharmaceutical Intermediates Market Segmentation: 10.1 Global Pharmaceutical Intermediates Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 10.2 Global Pharmaceutical Intermediates Market, Segmentation By Category, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 10.3 Global Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 10.4 Global Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
11 Pharmaceutical Intermediates Market, Regional and Country Analysis: 11.1 Global Pharmaceutical Intermediates Market, By Region, Historic and Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 11.2 Global Pharmaceutical Intermediates Market, By Country, Historic and Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
12 Asia-Pacific Market: 12.1 Summary; 12.2 Market Overview; 12.2.1 Region Information; 12.2.2 Market Information; 12.2.3 Background Information; 12.2.4 Government Initiatives; 12.2.5 Regulations; 12.2.6 Regulatory Bodies; 12.2.7 Major Associations; 12.2.8 Taxes Levied; 12.2.9 Corporate Tax Structure; 12.2.10 Investments; 12.2.11 Major Companies; 12.3 Asia-Pacific Pharmaceutical Intermediates Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 12.4 Asia-Pacific Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 12.5 Asia-Pacific Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 12.6 Asia-Pacific Pharmaceutical Intermediates Market: Country Analysis; 12.7 China Market; 12.8 Summary; 12.9 Market Overview; 12.9.1 Country Information; 12.9.2 Market Information; 12.9.3 Background Information; 12.9.4 Government Initiatives; 12.9.5 Regulations; 12.9.6 Regulatory Bodies; 12.9.7 Major Associations; 12.9.8 Taxes Levied; 12.9.9 Corporate Tax Structure; 12.9.10 Investments; 12.9.11 Major Companies; 12.10 China Pharmaceutical Intermediates Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 12.11 China Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 12.12 China Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 12.13 India Market; 12.14 India Pharmaceutical Intermediates Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 12.15 India Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 12.16 India Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 12.17 Japan Market; 12.18 Japan Pharmaceutical Intermediates Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 12.19 Japan Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 12.20 Japan Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 12.21 Australia Market; 12.22 Australia Pharmaceutical Intermediates Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 12.23 Australia Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 12.24 Australia Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 12.25 Indonesia Market; 12.26 Indonesia Pharmaceutical Intermediates Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 12.27 Indonesia Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 12.28 Indonesia Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 12.29 South Korea Market; 12.30 South Korea Pharmaceutical Intermediates Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 12.31 South Korea Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 12.32 South Korea Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
13 Western Europe Market: 13.1 Summary; 13.2 Market Overview; 13.2.1 Region Information; 13.2.2 Market Information; 13.2.3 Background Information; 13.2.4 Government Initiatives; 13.2.5 Regulations; 13.2.6 Regulatory Bodies; 13.2.7 Major Associations; 13.2.8 Taxes Levied; 13.2.9 Corporate Tax Structure; 13.2.10 Investments; 13.2.11 Major Companies; 13.3 Western Europe Pharmaceutical Intermediates Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 13.4 Western Europe Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 13.5 Western Europe Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 13.6 Western Europe Pharmaceutical Intermediates Market: Country Analysis; 13.7 UK Market; 13.8 UK Pharmaceutical Intermediates Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 13.9 UK Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 13.10 UK Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 13.11 Germany Market; 13.12 Germany Pharmaceutical Intermediates Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 13.13 Germany Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 13.14 Germany Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 13.15 France Market; 13.16 France Pharmaceutical Intermediates Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 13.17 France Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 13.18 France Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 13.19 Italy Market; 13.20 Italy Pharmaceutical Intermediates Market, Segmentation By Category, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 13.21 Italy Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 13.22 Italy Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 13.23 Spain Market; 13.24 Spain Pharmaceutical Intermediates Market, Segmentation By Category, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 13.25 Spain Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 13.26 Spain Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
14 Eastern Europe Market: 14.1 Summary; 14.2 Market Overview; 14.2.1 Region Information; 14.2.2 Market Information; 14.2.3 Background Information; 14.2.4 Government Initiatives; 14.2.5 Regulations; 14.2.6 Regulatory Bodies; 14.2.7 Major Associations; 14.2.8 Taxes Levied; 14.2.9 Corporate Tax Structure; 14.2.10 Investments; 14.2.11 Major Companies; 14.3 Eastern Europe Pharmaceutical Intermediates Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 14.4 Eastern Europe Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 14.5 Eastern Europe Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 14.6 Eastern Europe Pharmaceutical Intermediates Market: Country Analysis; 14.7 Russia Market; 14.8 Russia Pharmaceutical Intermediates Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 14.9 Russia Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 14.10 Russia Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
15 North America Market: 15.1 Summary; 15.2 Market Overview; 15.2.1 Region Information; 15.2.2 Market Information; 15.2.3 Background Information; 15.2.4 Government Initiatives; 15.2.5 Regulations; 15.2.6 Regulatory Bodies; 15.2.7 Major Associations; 15.2.8 Taxes Levied; 15.2.9 Corporate Tax Structure; 15.2.10 Investments; 15.2.11 Major Companies; 15.3 North America Pharmaceutical Intermediates Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 15.4 North America Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 15.5 North America Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 15.6 North America Pharmaceutical Intermediates Market: Country Analysis; 15.7 USA Market; 15.8 Summary; 15.9 Market Overview; 15.9.1 Country Information; 15.9.2 Market Information; 15.9.3 Background Information; 15.9.4 Government Initiatives; 15.9.5 Regulations; 15.9.6 Regulatory Bodies; 15.9.7 Major Associations; 15.9.8 Taxes Levied; 15.9.9 Corporate Tax Structure; 15.9.10 Investments; 15.9.11 Major Companies; 15.10 USA Pharmaceutical Intermediates Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 15.11 USA Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 15.12 USA Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 15.13 Canada Market; 15.14 Canada Pharmaceutical Intermediates Market, Segmentation By Category, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 15.15 Canada Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 15.16 Canada Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
16 South America Market: 16.1 Summary; 16.2 Market Overview; 16.2.1 Region Information; 16.2.2 Market Information; 16.2.3 Background Information; 16.2.4 Government Initiatives; 16.2.5 Regulations; 16.2.6 Regulatory Bodies; 16.2.7 Major Associations; 16.2.8 Taxes Levied; 16.2.9 Corporate Tax Structure; 16.2.10 Investments; 16.2.11 Major Companies; 16.3 South America Pharmaceutical Intermediates Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 16.4 South America Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 16.5 South America Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 16.6 South America Pharmaceutical Intermediates Market: Country Analysis; 16.7 Brazil Market; 16.8 Brazil Pharmaceutical Intermediates Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 16.9 Brazil Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 16.10 Brazil Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
17 Middle East Market: 17.1 Summary; 17.2 Market Overview; 17.2.1 Region Information; 17.2.2 Market Information; 17.2.3 Background Information; 17.2.4 Government Initiatives; 17.2.5 Regulations; 17.2.6 Regulatory Bodies; 17.2.7 Major Associations; 17.2.8 Taxes Levied; 17.2.9 Corporate Tax Structure; 17.2.10 Investments; 17.2.11 Major Companies; 17.3 Middle East Pharmaceutical Intermediates Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 17.4 Middle East Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 17.5 Middle East Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
18 Africa Market: 18.1 Summary; 18.2 Market Overview; 18.2.1 Region Information; 18.2.2 Market Information; 18.2.3 Background Information; 18.2.4 Government Initiatives; 18.2.5 Regulations; 18.2.6 Regulatory Bodies; 18.2.7 Major Associations; 18.2.8 Taxes Levied; 18.2.9 Corporate Tax Structure; 18.2.10 Investments; 18.2.11 Major Companies; 18.3 Africa Pharmaceutical Intermediates Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 18.4 Africa Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million); 18.5 Africa Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
19 Competitive Landscape and Company Profiles: 19.1 Company Profiles; 19.2 BASF SE; 19.2.1 Company Overview; 19.2.2 Products And Services; 19.2.3 Business Strategy; 19.2.4 Financial Overview; 19.3 Evonik Industries AG; 19.3.1 Company Overview; 19.3.2 Products And Services; 19.3.3 Business Strategy; 19.3.4 Financial Overview; 19.4 Pfizer Inc; 19.4.1 Company Overview; 19.4.2 Products And Services; 19.4.3 Business Strategy; 19.4.4 Financial Overview; 19.5 Arkema S.A.; 19.5.1 Company Overview; 19.5.2 Products And Services; 19.5.3 Business Strategy; 19.5.4 Financial Overview; 19.6 Koninklijke DSM N.V.; 19.6.1 Company Overview; 19.6.2 Products And Services; 19.6.3 Business Strategy; 19.6.4 Financial performance
20 Other Major And Innovative Companies: 20.1 Cambrex Corporation; 20.1.1 Company Overview; 20.1.2 Products And Services; 20.1.3 Business Strategy; 20.2 Lianhe Chemical Technology Co Ltd; 20.2.1 Company Overview; 20.2.2 Products And Services; 20.3 Ercros, S.A.; 20.3.1 Company Overview; 20.3.2 Products And Services; 20.3.3 Business Strategy; 20.4 Lonza Group AG; 20.4.1 Company Overview; 20.4.2 Products And Services; 20.4.3 1.4.3 Business Strategy; 20.5 Codexis, Inc; 20.5.1 Company Overview; 20.5.2 Products And Services; 20.5.3 Business Strategy; 20.6 Actylis; 20.6.1 Company Overview; 20.6.2 Products And Services; 20.6.3 Business Strategy; 20.7 Kuraray Co., Ltd; 20.7.1 Company Overview; 20.7.2 Products And Services; 20.8 Vertellus Holdings LLC; 20.8.1 Company Overview; 20.8.2 Products And Services; 20.9 Hikal Ltd; 20.9.1 Company Overview; 20.9.2 Products And Services; 20.10 WeylChem International GmbH; 20.10.1 Company Overview; 20.10.2 Products And Services; 20.10.3 Business Strategy
21 Competitive Benchmarking
22 Competitive Dashboard
23 Key Mergers And Acquisitions: 23.1 Hovione Acquired ExtremoChem; 23.2 Noramco Acquired The Cambrex Drug Product Business Unit; 23.3 Harmony Biosciences Acquired Zynerba Pharmaceuticals; 23.4 UBE Acquired API Corporation; 23.5 Cambrex Acquired Snapdragon Chemistry; 23.6 Sekhmet Pharmaventures Acquired Optimus Drugs; 23.7 SK Capital Partners Acquired A Majority Shareholding Of SEQENS; 23.8 Aceto Corporation Acquired Cascade Chemistry; 23.9 Wavelength Pharmaceuticals Acquired Vanamali Organics
24 Opportunities And Strategies: 24.1 Global Pharmaceutical Intermediates Market In 2028 – Countries Offering Most New Opportunities; 24.2 Global Pharmaceutical Intermediates Market In 2028 – Segments Offering Most New Opportunities; 24.3 Global Pharmaceutical Intermediates Market In 2028 – Growth Strategies; 24.3.1 Market Trend Based Strategies; 24.3.2 Competitor Strategies
25 Pharmaceutical Intermediates Market, Conclusions And Recommendations: 25.1 Conclusions; 25.2 Recommendations; 25.2.1 Product; 25.2.2 Place; 25.2.3 Price; 25.2.4 Promotion; 25.2.5 People
26 Appendix: 26.1 Geographies Covered; 26.2 Market Data Sources; 26.3 Research Methodology; 26.4 Currencies; 26.5 The Business Research Company; 26.6 Copyright and Disclaimer